Triall to Advance Blockchain Technology in Clinical Trials

JACKSONVILLE, Fla., Sept. 01, 2022 (GLOBE NEWSWIRE) — Triall, a blockchain-integrated eClinical platform provider, has collaborated with Mayo Clinic researchers to advance clinical trial design and study data management. . This collaboration marks an important step in leading a global transformation towards decentralized clinical research.

Triall’s eClinical platform will support a 2-year, multi-center pulmonary arterial hypertension trial that includes 10 investigational sites* and more than 500 patients in the United States, beginning in September of this year. Triall’s eClinical solutions will support all core trial activities, including data capture, document management, study tracking and electronic consent.

The collaboration takes a unique angle in demonstrating how Triall’s Verifiable Trial API can be applied to create immutable audit trails recorded on the blockchain as a new best practice for enforcing end-to-end clinical data integrity, from start to finish. the closure of the study. -Activities outside and after the study. As more data is collected from an ever-increasing number and variety of systems and devices, ensuring data integrity is a growing concern for clinical trial stakeholders and a major barrier to reliable and efficient medical research in clinical trials. the digital age.

The audit trail will provide a system-independent interface for investigators, monitors, IRBs, regulators, and other trial stakeholders to quickly assess the existence and completeness of trial-related documents and data, and their timeline in the trial process. This effort provides a platform for further potential collaboration between Mayo Clinic and Triall toward an evidence-based environment for decentralized clinical research, while reinforcing their mutual positions as thought leaders in clinical trial innovation.

“We are very excited to expand our collaboration with Mayo Clinic and the team at Chris McLeod, MD. It is wonderful to work with some of the thought leaders within Mayo Clinic, and we are confident that our collaboration will pave the way for more innovation and better quality.” in clinical development, using the strengths of blockchain technology where they really add value.” – Hadil Es-Sbai, Co-Founder and CEO of Triall

See also  Outlook on the Global Patient Experience Technology Market to 2027: Technological Advances on the Rise and New Releases in Current Patient Experience Technologies Opportunities - ResearchAndMarkets.com

About Triall
Triall offers a fully integrated, modular suite of eClinical solutions for all major study functions including EDC, ePRO/eCOA, eSource, eConsent, eTMF, CTMS, RTSM, portable integration and more. In addition, Triall applies blockchain to generate verifiable proof of clinical trial data integrity and leverages Self-Sovereign Identity (SSI) technologies to give patients and research professionals more ownership and control over their data, documents and processes.

For inquiries, please contact [email protected]

Visit the Triall website: https://www.triall.io

*List of participating research sites:

  • Advent Health
  • Aspirus Aurora Heart and Vascular
  • Brigham and Women’s Hospital
  • UCLA port
  • Mayo Clinic
  • my cardiologist
  • Jewish National Health
  • southeastern cardiology
  • Weill Cornell Medical Center
  • Wellstar Health System

related images

Image 1: Trial partners with Mayo Clinic

This content was issued through the press release distribution service at Newswire.com.

  • Trial partners with Mayo Clinic

Leave a Comment